Evidence map›Paper›PMID 41230509›Full record

ArticleFrontiers in neuroscience2025

White matter microstructure in mid- to late adulthood is influenced by pathway-stratified polygenic risk for Alzheimer's disease.

Judith R Harrison, Sonya F Foley, Emily Simmonds, Matthew Bracher-Smith, Peter Holmans, Evie Stergiakouli, Xavier Caseras, Valentina Escott-Price, Derek K Jones

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Judith R HarrisonInstitute of Neuroscience, Biomedical Research Building, Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne, United Kingdom.
Sonya F FoleyCardiff University Brain Research Imaging Centre (CUBRIC), Cardiff University, Cardiff, United Kingdom.
Emily SimmondsUK Dementia Research Institute, Division of Neuroscience and Mental Health, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Matthew Bracher-SmithUK Dementia Research Institute, Division of Neuroscience and Mental Health, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Peter HolmansDivision of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Evie StergiakouliBristol Medical School, University of Bristol, Bristol, United Kingdom.
Xavier CaserasDivision of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Valentina Escott-Price *UK Dementia Research Institute, Division of Neuroscience and Mental Health, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Derek K Jones *Cardiff University Brain Research Imaging Centre (CUBRIC), Cardiff University, Cardiff, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Alzheimer's disease involves progressive white matter microstructural degeneration that may precede clinical symptoms by decades. While polygenic risk scores (PRS) quantify cumulative genetic liability for AD, genome-wide PRS lack mechanistic specificity. We tested whether pathway-specific PRS, targeting areas of biology including tau binding, lipid metabolism, and immune response, are differentially associated with diffusion MRI measures across the lifespan. Methods: We analyzed two population-based cohorts: the Avon Longitudinal Study of Parents and Children (ALSPAC; mean age = 19.8 years, Results: In UK Biobank, higher PRS for protein-lipid complex assembly and tau protein binding were robustly associated with lower fractional anisotropy and higher mean diffusivity in both dorsal and parahippocampal cingulum segments (False discovery rate-corrected Conclusion: Pathway-specific polygenic risk for Alzheimer's disease manifests in white matter microstructure by mid- to late adulthood but not in early adulthood, suggesting an age-dependent emergence of genetic effects. dMRI phenotypes may thus serve as intermediate biomarkers for dissecting mechanistic pathways of preclinical Alzheimer's disease vulnerability.

Indexed as

ALSPACAlzheimer’s diseasediffusion magnetic resonance imaginggenetic predisposition to diseasegenome-wide association studylipid metabolismtau proteinswhite matter

Identifiers

PMID41230509
PMCPMC12602405

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.